KRAS and neoplasm: The use of discriminatory multi-target ddPCR assays hereby allows for direct KRAS SNV detection without prior tumor NGS, making it possible to assess tumor dynamics in a time-relevant co-clinical setting analogous to CA 19-9 levels [31,41].